Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Froyen

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Human Genetics|June 21, 2013
The mitochondrial solute carrier SLC25A5 at Xq24 is a novel candidate gene for non-syndromic intellectual disabilityJoke Vandewalle, Marijke Bauters, Hilde Van Esch, et al.
American Journal of Human Genetics|September 25, 2012
A noncoding, regulatory mutation implicates HCFC1 in nonsyndromic intellectual disabilityLingli Huang, Lachlan A Jolly, Saffron Willis-Owen, et al.
American Journal of Medical Genetics. Part A|June 5, 2003
Inv(X)(p21.1;q22.1) in a man with mental retardation, short stature, general muscle wasting, and facial dysmorphism: clinical study and mutation analysis of the NXF5 geneSuzanna G M Frints, Lin Jun, Jean-Pierre Fryns, et al.
Genome Research|April 4, 2008
Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repairMarijke Bauters, Hilde Van Esch, Michael J Friez, et al.
Journal of Medical Genetics|August 21, 2013
Deletion of the 5'exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndromeMaria João Nabais Sá, Nathalie Fieremans, Arjan P M de Brouwer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2007
Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humansYe Wu, Amy C Arai, Gavin Rumbaugh, et al.
Molecular Oncology|January 31, 2025
Analysis of comprehensive genomic profiling of solid tumors with a novel assay for broad analysis in clinical diagnosticsGuy Froyen, Pieter-Jan Volders, Ellen Geerdens, et al.
Frontiers in Digital Health|April 23, 2026
Advancing the adoption of oncology decision support tools in Europe: insights from CAN.HEALNancy Frederickx, Guy Froyen, Maud Kamal, et al.
Nature Communications|March 26, 2021
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entitiesBénedith Oben, Guy Froyen, Kylee H Maclachlan, et al.
American Journal of Human Genetics|July 31, 2012
Copy-number gains of HUWE1 due to replication- and recombination-based rearrangementsGuy Froyen, Stefanie Belet, Francisco Martinez, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Human Genetics|June 21, 2013
The mitochondrial solute carrier SLC25A5 at Xq24 is a novel candidate gene for non-syndromic intellectual disabilityJoke Vandewalle, Marijke Bauters, Hilde Van Esch, et al.
American Journal of Human Genetics|September 25, 2012
A noncoding, regulatory mutation implicates HCFC1 in nonsyndromic intellectual disabilityLingli Huang, Lachlan A Jolly, Saffron Willis-Owen, et al.
American Journal of Medical Genetics. Part A|June 5, 2003
Inv(X)(p21.1;q22.1) in a man with mental retardation, short stature, general muscle wasting, and facial dysmorphism: clinical study and mutation analysis of the NXF5 geneSuzanna G M Frints, Lin Jun, Jean-Pierre Fryns, et al.
Genome Research|April 4, 2008
Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repairMarijke Bauters, Hilde Van Esch, Michael J Friez, et al.
Journal of Medical Genetics|August 21, 2013
Deletion of the 5'exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndromeMaria João Nabais Sá, Nathalie Fieremans, Arjan P M de Brouwer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2007
Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humansYe Wu, Amy C Arai, Gavin Rumbaugh, et al.
Molecular Oncology|January 31, 2025
Analysis of comprehensive genomic profiling of solid tumors with a novel assay for broad analysis in clinical diagnosticsGuy Froyen, Pieter-Jan Volders, Ellen Geerdens, et al.
Frontiers in Digital Health|April 23, 2026
Advancing the adoption of oncology decision support tools in Europe: insights from CAN.HEALNancy Frederickx, Guy Froyen, Maud Kamal, et al.
Nature Communications|March 26, 2021
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entitiesBénedith Oben, Guy Froyen, Kylee H Maclachlan, et al.
American Journal of Human Genetics|July 31, 2012
Copy-number gains of HUWE1 due to replication- and recombination-based rearrangementsGuy Froyen, Stefanie Belet, Francisco Martinez, et al.
Pageof 8